ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 249.3 | 219.7 | 263.7 |
| Other income | 2.8 | 9.8 | 12.4 |
| Total income | 252.0 | 229.5 | 276.1 |
| Profit before exceptional items & tax | 77.7 | 62.6 | 99.6 |
| Profit before tax | 77.7 | 62.6 | 99.6 |
| Net profit | 58.3 | 45.9 | 74.1 |
| Operating margin | 30.8% | 27.3% | 36.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -21.30% |
|---|---|
| Net profit, quarter on quarter | +27.00% |
| Revenue, year on year | -5.50% |
BSE results filing, NSE: CLEAN. Figures extracted from the filing.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹714.00
- Market cap
- ₹7,589 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.5×Sector 35.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Earnings Call Transcript: Key Takeaways
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Clean Science & Technology Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.